Suppr超能文献

相似文献

1
Type beta transforming growth factor/growth inhibitor stimulates entry of monolayer cultures of AKR-2B cells into S phase after a prolonged prereplicative interval.
Proc Natl Acad Sci U S A. 1985 Jun;82(12):4147-51. doi: 10.1073/pnas.82.12.4147.
2
Transforming growth factor type beta can act as a potent competence factor for AKR-2B cells.
Exp Cell Res. 1987 Oct;172(2):293-303. doi: 10.1016/0014-4827(87)90388-0.
3
Effects of N,N-dimethylformamide and retinoic acid on transforming growth factor-beta induced mitogenesis in AKR-2B mouse embryo fibroblasts.
Cancer Res. 1987 Aug 15;47(16):4278-82.
4
Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.
J Cell Physiol. 1987 Jul;132(1):143-8. doi: 10.1002/jcp.1041320120.
5
Insulin-like synergistic stimulation of DNA synthesis in Swiss 3T3 cells by the BSC-1 cell-derived growth inhibitor related to transforming growth factor type beta.
Proc Natl Acad Sci U S A. 1987 Jun;84(11):3743-7. doi: 10.1073/pnas.84.11.3743.
6
Differential effects of epidermal growth factor, transforming growth factor, and insulin on DNA and protein synthesis and morphology in serum-free cultures of AKR-2B cells.
Cancer Res. 1984 Feb;44(2):710-6.
7
Specific induction of secreted proteins by transforming growth factor-beta and 12-O-tetradecanoylphorbol-13-acetate. Relationship with an inhibitor of plasminogen activator.
J Biol Chem. 1987 Feb 15;262(5):2283-90.
8
Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type beta transforming growth factor.
Cancer Res. 1986 May;46(5):2330-4.
9
Effects of transforming growth factor-beta, transforming growth factor-alpha, and other growth factors on renal proximal tubule cells.
Lab Invest. 1991 Apr;64(4):538-45.
10
Transforming growth factor beta (TGF-beta) inhibits hepatocyte DNA synthesis independently of EGF binding and EGF receptor autophosphorylation.
J Cell Physiol. 1988 May;135(2):253-61. doi: 10.1002/jcp.1041350212.

引用本文的文献

1
Advances and Challenges in Targeting TGF-β Isoforms for Therapeutic Intervention of Cancer: A Mechanism-Based Perspective.
Pharmaceuticals (Basel). 2024 Apr 20;17(4):533. doi: 10.3390/ph17040533.
2
Targeting TGFβ signal transduction for cancer therapy.
Signal Transduct Target Ther. 2021 Jan 8;6(1):8. doi: 10.1038/s41392-020-00436-9.
3
TGF-beta in mammary development and neoplasia.
J Mammary Gland Biol Neoplasia. 1996 Oct;1(4):327-9. doi: 10.1007/BF02017388.
4
The role of transforming growth factor beta in glioma progression.
J Neurooncol. 1998 Jan;36(2):123-40. doi: 10.1023/a:1005863419880.
5
Ehrlich ascites tumor cells produce a transforming growth factor-beta (TGFbeta)-like activity but lack receptors with TGFbeta-binding capacity.
Mol Cell Biochem. 1997 May;170(1-2):153-62. doi: 10.1023/a:1006809604193.
6
Transforming growth factor beta as a potential tumor progression factor among hyperdiploid glioblastoma cultures: evidence for the role of platelet-derived growth factor.
J Neurooncol. 1997 Feb;31(3):233-54. doi: 10.1023/a:1005767616500.
7
TGF-beta gene expression depends on tissue architecture.
In Vitro Cell Dev Biol. 1993 Feb;29A(2):105-8. doi: 10.1007/BF02630937.
8
Role of the latent TGF-beta binding protein in the activation of latent TGF-beta by co-cultures of endothelial and smooth muscle cells.
J Cell Biol. 1993 Feb;120(4):995-1002. doi: 10.1083/jcb.120.4.995.
9
Plasmin cleaves betaglycan and releases a 60 kDa transforming growth factor-beta complex from the cell surface.
Biochem J. 1994 Aug 15;302 ( Pt 1)(Pt 1):199-205. doi: 10.1042/bj3020199.
10
Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression.
J Cell Biol. 1994 Nov;127(4):1121-7. doi: 10.1083/jcb.127.4.1121.

本文引用的文献

1
Improved medium and culture conditions for clonal growth with minimal serum protein and for enhanced serum-free survival of Swiss 3T3 cells.
In Vitro. 1981 Aug;17(8):656-70. doi: 10.1007/BF02628401.
2
Purification of kidney epithelial cell growth inhibitors.
Proc Natl Acad Sci U S A. 1980 Oct;77(10):5989-92. doi: 10.1073/pnas.77.10.5989.
3
Serum contains a platelet-derived transforming growth factor.
Proc Natl Acad Sci U S A. 1982 Sep;79(17):5312-6. doi: 10.1073/pnas.79.17.5312.
4
Activity of a kidney epithelial cell growth inhibitor on lung and mammary cells.
Cell Biol Int Rep. 1983 Feb;7(2):141-7. doi: 10.1016/0309-1651(83)90027-9.
5
Epidermal growth factor (EGF) and somatomedin C regulate G1 progression in competent BALB/c-3T3 cells.
Exp Cell Res. 1982 Sep;141(1):107-15. doi: 10.1016/0014-4827(82)90073-8.
6
Purification and properties of a type beta transforming growth factor from bovine kidney.
Biochemistry. 1983 Dec 6;22(25):5692-8. doi: 10.1021/bi00294a002.
7
Purification and initial characterization of a type beta transforming growth factor from human placenta.
Proc Natl Acad Sci U S A. 1983 Jun;80(12):3676-80. doi: 10.1073/pnas.80.12.3676.
8
Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.
J Biol Chem. 1983 Jun 10;258(11):7155-60.
9
Differential effects of epidermal growth factor, transforming growth factor, and insulin on DNA and protein synthesis and morphology in serum-free cultures of AKR-2B cells.
Cancer Res. 1984 Feb;44(2):710-6.
10
Transforming growth factor-beta controls receptor levels for epidermal growth factor in NRK fibroblasts.
Cell. 1984 Jan;36(1):35-41. doi: 10.1016/0092-8674(84)90071-0.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验